Compounds > 1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine
Page last updated: 2024-09-05

1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine and tavaborole

1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine has been researched along with tavaborole in 1 studies

Compound Research Comparison

Studies
(1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine)		Trials
(1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine)		Recent Studies (post-2010)
(1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine)		Studies
(tavaborole)		Trials
(tavaborole)		Recent Studies (post-2010) (tavaborole)
140375963

Protein Interaction Comparison

ProteinTaxonomy1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine (IC50)tavaborole (IC50)
Leucine--tRNA ligase, cytoplasmicSaccharomyces cerevisiae S288C2.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Adil Shareef, M; Das, BC; Das, S; Das, Y; Nandwana, NK; Saito, M; Weiss, LM1

Reviews

1 review(s) available for 1,2-dihydro-1-hydroxy-6-methyl-2-(propanesulfonyl)-thieno(3,2d)(1,2,3)-diazaborine and tavaborole

ArticleYear
Boron-Containing heterocycles as promising pharmacological agents.
    Bioorganic & medicinal chemistry, 2022, 06-01, Volume: 63

    Topics: Boron; Bortezomib; Chemistry, Pharmaceutical

2022